Clinical trial · Observational
Oncological Safety of Oncoplastic Breast Surgery in Multicentric Breast Cancer
Oncological Safety of Oncoplastic Breast Surgery in Multicentric Breast Retrospective Study
NCT06926335CI-TRIAL-00088632active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate Oncological safety of oncoplastic breast surgery in multicentric breast cancer
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Multicentric | — | UNRESOLVED | — |
| Safety of Breast Coservative Multicenteric Breast Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breast consevative surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To evaluate Oncological safety of oncoplastic breast surgery in multicentric breast cancer
- timeFrame
- 5 years
- description
- Number of multicentric breast cancer who underwent breast conservative surgery with no recurrance
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients with multicentric breast cancer * Female Patient aged from 18 to 65 years old * Patients who are fit for general anesthesia. * Patients who provide a written informed consent. * Patient who agree to provide short term outcome data and agree to provide contact information to provide contact information Exclusion Criteria: * Female patients less than 20 years old * Stage 4 breast cancer * Patients who are contraindicated for radiotherapy * Pregnant patients in first trimester * Patient with inflammatory carcinoma
References
Publications (0)
Data not yet available
No reference posted for this study.